Cutler Group’s GeneDx Holdings WGS Stock Holding History

Cutler Group’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-97	Closed	-$6K	–	6182
2021 Q3	$6K	Buy	97 +27	+39%	+$9.27K	﹤0.01%	4370
2021 Q2	$10K	Hold	70	–	–	﹤0.01%	3941
2021 Q1	$12K	Buy	+70	New	+$36.4K	﹤0.01%	3682

Other funds holding WGS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Cutler Group's WGS Position: Q1 2023 in Review

Cutler Group sold out of GeneDx Holdings (WGS) in Q1 2023, closing a stake of 53 shares.

Cutler Group first reported a position in WGS in Q2 2021 and held it in 7 quarters. The position peaked at $91K in Q3 2021. 82 funds tracked by Wall St. Rank hold WGS as of Q1 2023.

Cutler Group reported no remaining GeneDx Holdings position as of Q1 2023 after selling out during the quarter.
Cutler Group sold 53 GeneDx Holdings shares in Q1 2023.
Cutler Group first reported a position in GeneDx Holdings in Q2 2021 and held it in 7 quarters.
Cutler Group's GeneDx Holdings position peaked at $91K in Q3 2021.
82 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.